Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1adolescentsbariatric-surgeryjama-pediatrics

JAMA Pediatrics study tracks GLP-1 use versus bariatric surgery in teens

The cross-sectional analysis follows quarterly prescribing and surgical trends among adolescents who met eligibility criteria for metabolic and bariatric surgery.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 4 20:00 ETSource: JAMA pediatrics

The wire

  1. 01A cross-sectional study published in JAMA Pediatrics assesses quarterly trends in GLP-1 receptor agonist prescribing and metabolic and bariatric surgery use among surgery-eligible adolescents.
  2. 02Pediatric and adolescent obesity clinicians are weighing incretin therapy against surgical referral, and utilization data informs how that balance is shifting in practice.
  3. 03The design is cross-sectional and descriptive, so it shows utilization patterns rather than comparative outcomes, durability or safety between the two approaches.

From the source

Metabolic and Bariatric Surgery and GLP-1 Receptor Agonist Use Among Adolescents

JAMA pediatrics · 2026 Oct 5 · Rode JB, Inge TH, Wu AD et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →